Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men.

by Karim Zouaoui Boudjeltia, Brice Faraut, Maria José Esposito, Patricia Stenuit, Michal Dyzma, Pierre Van Antwerpen, Dany Brohée, Luc Vanhamme, Nicole Moguilevsky, Michel Vanhaeverbeek, Myriam Kerkhofs
Published 2011-01-01

Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men

by Karim Zouaoui Boudjeltia, Cédric Delporte, Pierre Van Antwerpen, Thierry Franck, Didier Serteyn, Nicole Moguilevsky, Martine Raes, Luc Vanhamme, Michel Vanhaeverbeek, Alain Van Meerhaeghe, Thierry Roumeguère
Published 2013-01-01

Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis.

by Karim Zouaoui Boudjeltia, Jalil Daher, Pierre Van Antwerpen, Nicole Moguilevsky, Paul Delree, Jean Ducobu, Martine Raes, Bassam Badran, Michel Vanhaeverbeek, Dany Brohee, Claude Remacle, Luc Vanhamme
Published 2012-01-01